Clinical Trial to Evaluate the Efficacy and Safety of 'GLA5PR GLARS-NF1 Tab.' in Peripheral Neuropathic Pain

NCT03221907 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

352

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain of Mononeuropathy

Interventions

DRUG: GLA5PR GLARS-NF1
DRUG: GLA5PR GLARS-NF1 placebo
DRUG: Pregabalin
DRUG: Pregabalin placebo

Sponsor

Daewon Pharmaceutical Co., Ltd.